maternity preeclampsia - Nursing Case Study
Pathophysiology
• Primary mechanism: Abnormal placentation leads to impaired remodeling of the spiral arteries, resulting in reduced placental perfusion and ischemia. This causes the release of antiangiogenic factors into the maternal circulation, leading to widespread endothelial dysfunction.
• Secondary mechanism: Endothelial dysfunction triggers systemic vasoconstriction and increased vascular permeability, causing hypertension and edema. The resulting increase in blood pressure can lead to decreased organ perfusion, notably affecting the kidneys and liver.
• Key complication: If untreated, preeclampsia can progress to eclampsia, characterized by seizures, and can lead to serious maternal and fetal complications, including organ failure, placental abruption, and preterm birth.
Patient Profile
Demographics:
29-year-old female, teacher
History:
• Key past medical history: Gestational hypertension in previous pregnancy
• Current medications: Prenatal vitamins, Labetalol 100 mg twice daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Persistent headache and visual disturbances
• Key symptoms: Swelling in hands and feet, upper abdominal pain, nausea
• Vital signs: Blood pressure 160/105 mmHg, heart rate 92 bpm, respiratory rate 20 breaths per minute, temperature 98.6°F, oxygen saturation 98% on room air
Section 1
As the clinical team continues to monitor the patient, her initial assessment findings reveal concerning developments. During a focused physical examination, the patient exhibits brisk deep tendon reflexes, rated at 3+, indicating heightened neuromuscular excitability, a sign of worsening preeclampsia. Her urine dipstick test shows 2+ proteinuria, suggesting significant kidney involvement. These findings are consistent with the systemic endothelial dysfunction characteristic of preeclampsia. Additionally, the patient reports increased severity of her headache and visual disturbances, which are not alleviated by rest or hydration, raising concern for potential cerebral involvement.
Laboratory results return, providing further insight into the patient's condition. Her complete blood count shows a hematocrit of 38%, which is within normal limits, but her platelet count has decreased to 110,000/mm³, indicating thrombocytopenia. Liver function tests reveal elevated alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, at 85 U/L and 92 U/L respectively, reflecting hepatic involvement. These findings suggest that the patient is developing HELLP syndrome, a severe form of preeclampsia characterized by hemolysis, elevated liver enzymes, and low platelet count. This progression necessitates immediate intervention to prevent further complications.
Given these developments, the healthcare team recognizes the urgency of stabilizing the patient to prevent progression to eclampsia. The obstetrician recommends initiating magnesium sulfate therapy to reduce the risk of seizures and closely monitoring the fetal status through continuous electronic fetal monitoring. The patient's blood pressure management is intensified, increasing the dose of Labetalol and considering alternative antihypertensive agents. The team also prepares for the potential need for expedited delivery, balancing the risks of preterm birth with the need to protect maternal health. These actions are critical to managing the patient's evolving condition and mitigating the risks associated with severe preeclampsia and HELLP syndrome.
Section 2
As the clinical team continues to manage the patient's condition, a change in her status is observed, necessitating immediate reevaluation of the treatment plan. Despite the administration of magnesium sulfate, the patient experiences an acute episode of severe hypertension, with blood pressure readings escalating to 190/120 mmHg. This hypertensive crisis compels the healthcare team to reassess her antihypertensive regimen, opting to introduce hydralazine as an adjunctive therapy to achieve more rapid blood pressure control.
Concurrently, the patient's neurological symptoms escalate, with reports of persistent and worsening visual disturbances, including scotomas and photophobia. These symptoms, coupled with her labile blood pressure, raise the suspicion of imminent eclampsia, prompting the team to prepare for emergency interventions. The decision is made to increase the frequency of neurological assessments, monitoring for signs of seizure activity, and ensuring the availability of emergency seizure management protocols.
Meanwhile, the continuous electronic fetal monitoring reveals signs of fetal distress, characterized by recurrent late decelerations and decreased variability in the fetal heart rate tracing. This development indicates that the fetus is experiencing compromised oxygenation, likely a consequence of the severe maternal condition. Given these findings, the obstetric team determines that the risks associated with continued intrauterine life outweigh those of preterm delivery. Preparations are made for an expedited cesarean delivery to ensure both maternal and fetal safety, underscoring the critical need for timely intervention in the face of severe preeclampsia and HELLP syndrome.
Section 3
As the healthcare team responds to the evolving situation, the patient's neurological status undergoes further deterioration. Despite the administration of magnesium sulfate and ongoing antihypertensive therapy, the patient experiences a generalized tonic-clonic seizure, confirming the progression to eclampsia. The rapid response team initiates emergency seizure management protocols, administering an additional bolus of magnesium sulfate while ensuring airway protection and supplemental oxygen to maintain adequate maternal and fetal oxygenation.
Concurrently, new laboratory results reveal a significant worsening of the patient's condition. Her complete blood count indicates thrombocytopenia, with platelet counts dropping to 80,000/µL. Liver function tests show elevated liver enzymes, with AST and ALT levels rising to 200 U/L and 250 U/L, respectively. These findings confirm the development of HELLP syndrome, a severe complication of preeclampsia characterized by hemolysis, elevated liver enzymes, and low platelet count. The increased risk of bleeding and hepatic complications necessitates an urgent reassessment of the patient's coagulation status and potential need for blood product support.
In response to these critical developments, the obstetric and neonatal teams expedite preparations for an emergency cesarean delivery. With the patient's condition rapidly deteriorating and fetal distress persisting, the multidisciplinary team collaborates closely to ensure a coordinated approach to stabilize the mother and optimize neonatal outcomes. The anesthesiology team is alerted to the potential challenges posed by the patient's coagulopathy and prepares for possible complications during anesthesia administration. This swift and decisive action highlights the importance of timely and coordinated interventions in managing severe preeclampsia and its complications.
Section 4
As the multidisciplinary team moves quickly to stabilize the patient for an emergency cesarean delivery, they encounter a new complication: acute pulmonary edema. The patient begins to exhibit signs of respiratory distress, including tachypnea with a respiratory rate of 30 breaths per minute, diffuse crackles upon auscultation, and an oxygen saturation that has dropped to 88% on room air. These findings suggest fluid overload, likely exacerbated by aggressive fluid resuscitation and impaired renal function secondary to the worsening HELLP syndrome.
Immediate interventions are initiated to address the pulmonary complications. The patient is placed in an upright position to facilitate lung expansion, and supplemental oxygen is increased to maintain adequate saturation levels. Diuretics are considered as part of the management strategy to reduce fluid overload, but the team remains cautious given the patient's coagulopathy and renal status. A chest X-ray is ordered to assess the extent of pulmonary involvement and guide further treatment decisions.
Simultaneously, the neonatal team monitors fetal well-being closely, noting persistent late decelerations on the fetal heart tracing, indicating ongoing fetal distress. Continuous fetal monitoring is prioritized to assess the need for immediate delivery should further deterioration occur. As the team prepares for the cesarean delivery, they remain vigilant in monitoring the patient’s cardiopulmonary status and are ready to adapt the anesthesia plan to address any instability. This complex scenario underscores the need for swift decision-making and the ability to anticipate and manage new complications in the setting of severe preeclampsia and HELLP syndrome.
Section 5
As the team continues to manage the acute pulmonary complications, new diagnostic results provide further insight into the patient's condition. The chest X-ray confirms the presence of bilateral pulmonary edema, consistent with fluid overload. Additionally, laboratory results reveal a further decline in renal function, with creatinine levels rising to 2.3 mg/dL, indicating acute kidney injury likely aggravated by the ongoing HELLP syndrome. Liver function tests show increasing AST and ALT levels, now at 400 U/L and 350 U/L respectively, pointing to worsening liver involvement. Platelet counts have dropped to 45,000/µL, heightening the risk for bleeding complications.
In light of these findings, the team deliberates on the balance between diuresis and maintaining circulatory stability. A low-dose loop diuretic is cautiously administered to facilitate diuresis while closely monitoring for any adverse effects on renal function and hemodynamic stability. The patient's oxygen saturation improves to 92% with high-flow oxygen, and her respiratory rate stabilizes at 24 breaths per minute, suggesting a positive response to the initial respiratory interventions.
Despite these efforts, the fetal heart rate monitoring continues to show late decelerations, with minimal variability, indicating persistent fetal distress. Given the maternal and fetal conditions, the decision is made to proceed with the emergency cesarean delivery. The anesthesia team opts for a general anesthetic approach due to the patient's coagulopathy, ensuring rapid induction while minimizing the risk of bleeding complications. As the surgical team prepares for the procedure, the importance of swift yet careful management is underscored, with all team members remaining alert to the evolving clinical picture and ready to respond to any further complications.